Skip to main content
. 2018;25(1):7–13. doi: 10.6001/actamedica.v25i1.3698

Table 3.

Table of results of allele frequency evaluation in the study groups

Gene SNV Variant Case group MAF* Control group MAF* p value OR
ADH5 rs7669660 NM_000671:c.*966T>C 0.08 0.10 0.5257 0.77
ADH5 rs11547772 NM_000671:c.*775T>G 0.05 0.05 0.8938 0.93
ADH5 rs6827292 NM_000671:c.*574T>C 0.03 0.05 0.4919 0.68
ADH5 rs1803037 NM_000671.4:c.*417G>A 0.05 0.05 0.8938 0.93
ADH4 rs1042364 NM_000670.4:c.*19A>G 0.34 0.24 0.0982 1.57
ADH4 rs1126673 NM_000670.4:c.1120G>A 0.38 0.33 0.3833 1.25
ADH4 rs1126672 NM_000670.4:c.1051C>T 0.34 0.24 0.0982 1.57
ADH4 rs1126671 NM_000670.4:c.925A>G 0.38 0.33 0.3653 1.26
ADH7 rs284787 NM_000673:c.*749C>T 0.24 0.28 0.3738 0.79
ADH7 rs3805331 NM_000673:c.*373T>C 0.05 0.06 0.6708 0.81
ADH7 rs971074 NM_000673.4:c.690G>A 0.13 0.15 0.7696 0.91
ADH7 rs17537595 NM_000673:c.-40T>C 0.16 0.15 0.7518 1.11
OPRM1 rs6912029 NM_000914:c.-172C>A 0.04 0.05 0.5588 0.72
OPRM1 rs1799971 NM_000914.4:c.118A>G 0.07 0.07 0.9988 1.00
OPRM1 rs563649 NM_001145287:c.-3004G>A 0.10 0.10 0.9836 0.99
OPRM1 rs650245 NM_001145286:c.*4A>G 0.08 0.10 0.6153 0.82
IPCEF1 rs9479767 NM_001130699:c.*4435T>C 0.46 0.54 0.1777 0.73
IPCEF1 rs17277929 NM_001130699:c.*3050T>C 0.09 0.07 0.5631 1.30
IPCEF1 rs2236256 NM_001130699:c.*2523G>T 0.46 0.54 0.1777 0.73
IPCEF1 rs2236259 NM_001130699:c.*2070T>C 0.46 0.54 0.1777 0.73
NPY rs16139 NM_000905.3:c.20T>C 0.06 0.02 0.1963 2.52
DPYSL2 rs708621 NM_001197293.2:c.1821T>C 0.30 0.26 0.4142 1.25
DPYSL2 rs1058332 NM_001197293:c.*1071G>A 0.10 0.05 0.1586 2.09
DPYSL2 rs920633 NM_001197293:c.*1557A>G 0.14 0.09 0.1575 1.79
DPYSL2 rs17666 NM_001197293:c.*2236A>G 0.29 0.29 0.9738 1.01
ALDH1A1 rs8188000 NM_000689:c.*455T>C 0.07 0.11 0.2225 0.62
ALDH1A1 rs13959 NM_000689.4:c.225C>T 0.42 0.35 0.2507 1.33
GAD2 rs2236418 NM_000818:c.-243A>G 0.21 0.21 0.9968 1.00
CYP2E1 rs6413419 NM_000773.3:c.535G>A 0.01 0.00 0.2840 NA
CYP2E1 rs2515641 NM_000773.3:c.1263C>G 0.13 0.09 0.2695 1.58
ANKK1 rs17115439 NM_178510.1:c.255T>C 0.32 0.25 0.2264 1.39
ANKK1 rs4938013 NM_178510.1:c.453A>C 0.33 0.26 0.2061 1.41
ANKK1 rs7118900 NM_178510.1:c.715G>A 0.16 0.12 0.3990 1.35
ANKK1 rs4938016 NM_178510.1:c.1324G>C 0.36 0.29 0.2126 1.38
ANKK1 rs2734849 NM_178510.1:c.1469A>G 0.48 0.59 0.0719 0.65
ANKK1 rs2734848 NM_178510.1:c.1683C>T 0.18 0.15 0.4843 1.26
HTR3B rs1176744 NM_006028.4:c.386A>C 0.28 0.29 0.7644 0.92
HTR3B rs17116138 NM_006028.4:c.547G>A 0.04 0.05 0.5588 0.72
HTR2A rs9595552 NM_001165947:c.*1542T>C 0.07 0.06 0.8508 1.10
HTR2A rs6314 NM_000621.4:c.1354C>T 0.07 0.06 0.7846 1.14
HTR2A rs6313 NM_000621.4:c.102C>T 0.32 0.37 0.3725 0.80
NALCN rs8922 NM_052867.2:c.*1454T>G 0.22 0.22 0.9656 0.99
NALCN rs682767 NM_052867.2:c.*1018T>C 0.38 0.45 0.2296 0.75
NALCN rs682666 NM_052867.2:c.*946C>T 0.39 0.45 0.2578 0.76
NALCN rs9557581 NM_052867.2:c.*931A>G 0.38 0.45 0.2296 0.75
NALCN rs1289556 NM_052867.2:c.4416A>C 0.38 0.33 0.4210 1.23
NALCN rs17677552 NM_052867.2:c.3714C>T 0.37 0.30 0.2721 1.33
NALCN rs686141 NM_052867.2:c.3570T>C 0.27 0.38 0.0409 0.60
CHRNA3 rs660652 NM_000743:c.*1114T>C 0.36 0.33 0.5473 1.16
CHRNA3 rs472054 NM_000743:c.*952T>C 0.36 0.33 0.5536 1.16
CHRNA3 rs578776 NM_000743:c.*546C>T 0.25 0.24 0.8608 1.05
CHRNA3 rs1051730 NM_000743.4:c.645C>T 0.38 0.43 0.3940 0.81
CHRNA3 rs8040868 NM_000743.4:c.159A>G 0.42 0.46 0.4470 0.83
CHRNA3 rs8192475 NM_000743.4:c.110G>A 0.03 0.04 0.8898 0.92
SLC6A4 rs3813034 NM_001045:c.*670T>G 0.43 0.48 0.4897 0.85
SLC6A4 rs1042173 NM_001045:c.*463T>G 0.43 0.48 0.4897 0.85
SLC6A4 rs6354 NM_001045:c.-922G>T 0.18 0.21 0.5214 0.83
COMT rs4633 NM_000754.3:c.186C>T 0.46 0.51 0.3659 0.81
COMT rs4680 NM_000754.3:c.472G>A 0.46 0.51 0.3659 0.81
COMT rs769224 NM_000754.3:c.597G>A 0.04 0.07 0.1405 0.50
COMT rs165599 NM_000754.3:c.*522G>A 0.35 0.44 0.1277 0.69
COMT rs165728 NM_000754.3:c.*764C>T 0.11 0.17 0.1193 0.60

* MAF – Minor Allele Frequency

p value – Pearson’s Chi squared test p value

‡ OR – Odds Ratio

Statistically significant results are bolded